06160.HK
BeOne Medicines AG
HKSE · Healthcare · Biotechnology · CH
HKD 220.80
+1.19%Forward multiples
Based on analyst estimates
- P/E forward
- 46.65x
- P/E 2026E
- 49.18x
- P/E 2027E
- 36.11x
- P/E 2028E
- 26.65x
- P/S forward
- 5.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- 61.90x
- PEG TTM
- 1.89x
- Price / book
- 7.85x
- Price / sales
- 6.63x
- Price / cash flow
- 27.29x
Enterprise value
- Enterprise value
- HKD 287.5B
- EV / sales
- 5.99x
- EV / EBITDA
- 33.21x
- EV / EBIT
- 39.76x
- Market cap
- HKD 318.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026